186 related articles for article (PubMed ID: 30194234)
21. Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with
Cai Z; Yook S; Lu Y; Bergstrom D; Winnik MA; Pignol JP; Reilly RM
Pharm Res; 2017 Mar; 34(3):579-590. PubMed ID: 27987070
[TBL] [Abstract][Full Text] [Related]
22. Rational Surface Design of Upconversion Nanoparticles with Polyethylenimine Coating for Biomedical Applications: Better Safe than Brighter?
Guller AE; Nadort A; Generalova AN; Khaydukov EV; Nechaev AV; Kornienko IA; Petersen EV; Liang L; Shekhter AB; Qian Y; Goldys EM; Zvyagin AV
ACS Biomater Sci Eng; 2018 Sep; 4(9):3143-3153. PubMed ID: 33435055
[TBL] [Abstract][Full Text] [Related]
23. Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy.
Chen Q; Wang C; Cheng L; He W; Cheng Z; Liu Z
Biomaterials; 2014 Mar; 35(9):2915-23. PubMed ID: 24412081
[TBL] [Abstract][Full Text] [Related]
24. 808 nm-excited upconversion nanoprobes with low heating effect for targeted magnetic resonance imaging and high-efficacy photodynamic therapy in HER2-overexpressed breast cancer.
Zeng L; Pan Y; Zou R; Zhang J; Tian Y; Teng Z; Wang S; Ren W; Xiao X; Zhang J; Zhang L; Li A; Lu G; Wu A
Biomaterials; 2016 Oct; 103():116-127. PubMed ID: 27376560
[TBL] [Abstract][Full Text] [Related]
25. Active targeting of block copolymer micelles with trastuzumab Fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts.
Hoang B; Ekdawi SN; Reilly RM; Allen C
Mol Pharm; 2013 Nov; 10(11):4229-41. PubMed ID: 24066900
[TBL] [Abstract][Full Text] [Related]
26. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy.
Gao C; Lin Z; Wu Z; Lin X; He Q
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34252-34260. PubMed ID: 27936561
[TBL] [Abstract][Full Text] [Related]
27. Riboflavin photoactivation by upconversion nanoparticles for cancer treatment.
Khaydukov EV; Mironova KE; Semchishen VA; Generalova AN; Nechaev AV; Khochenkov DA; Stepanova EV; Lebedev OI; Zvyagin AV; Deyev SM; Panchenko VY
Sci Rep; 2016 Oct; 6():35103. PubMed ID: 27731350
[TBL] [Abstract][Full Text] [Related]
28. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice.
Cheng L; Yang K; Shao M; Lu X; Liu Z
Nanomedicine (Lond); 2011 Oct; 6(8):1327-40. PubMed ID: 21834646
[TBL] [Abstract][Full Text] [Related]
29. Selection, purification, and characterization of a HER2-targeting soluble designed ankyrin repeat protein by E. coli surface display using HER2-positive melanoma cells.
Chen X; Yu X; Song X; Liu L; Yi Y; Yao W; Gao X
Prep Biochem Biotechnol; 2018 Feb; 48(2):144-150. PubMed ID: 29313422
[TBL] [Abstract][Full Text] [Related]
30. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
Wang C; Cheng L; Liu Z
Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
[TBL] [Abstract][Full Text] [Related]
31. Nanodiamonds conjugated upconversion nanoparticles for bio-imaging and drug delivery.
Zhang K; Zhao Q; Qin S; Fu Y; Liu R; Zhi J; Shan C
J Colloid Interface Sci; 2019 Mar; 537():316-324. PubMed ID: 30448652
[TBL] [Abstract][Full Text] [Related]
32. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
D'Huyvetter M; Aerts A; Xavier C; Vaneycken I; Devoogdt N; Gijs M; Impens N; Baatout S; Ponsard B; Muyldermans S; Caveliers V; Lahoutte T
Contrast Media Mol Imaging; 2012; 7(2):254-64. PubMed ID: 22434639
[TBL] [Abstract][Full Text] [Related]
33. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
34. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles.
Wang C; Tao H; Cheng L; Liu Z
Biomaterials; 2011 Sep; 32(26):6145-54. PubMed ID: 21616529
[TBL] [Abstract][Full Text] [Related]
35. Preparation and
Okarvi SM; Aljammaz I
Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
[TBL] [Abstract][Full Text] [Related]
36. An upconversion nanoplatform with extracellular pH-driven tumor-targeting ability for improved photodynamic therapy.
Ai F; Wang N; Zhang X; Sun T; Zhu Q; Kong W; Wang F; Zhu G
Nanoscale; 2018 Mar; 10(9):4432-4441. PubMed ID: 29451577
[TBL] [Abstract][Full Text] [Related]
37. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
38. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
[TBL] [Abstract][Full Text] [Related]
39. Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy.
Liu F; He X; Lei Z; Liu L; Zhang J; You H; Zhang H; Wang Z
Adv Healthc Mater; 2015 Mar; 4(4):559-68. PubMed ID: 25471617
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
